Roswitha Gerhards

483 total citations
10 papers, 374 citations indexed

About

Roswitha Gerhards is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Roswitha Gerhards has authored 10 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Epidemiology. Recurrent topics in Roswitha Gerhards's work include Virus-based gene therapy research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Virology and Viral Diseases (3 papers). Roswitha Gerhards is often cited by papers focused on Virus-based gene therapy research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Virology and Viral Diseases (3 papers). Roswitha Gerhards collaborates with scholars based in Germany and Switzerland. Roswitha Gerhards's co-authors include Volker Schirrmacher, C Haas, R Bonifer, T. Ahlert, Christel Herold‐Mende, Raimund Firsching, Elmar Kirches, Thomas Schneider, E. Hagmüller and R. Voigtmann and has published in prestigious journals such as Annals of Oncology, Journal of General Virology and Journal of Cellular Biochemistry.

In The Last Decade

Roswitha Gerhards

10 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roswitha Gerhards Germany 8 170 150 144 114 101 10 374
R Bonifer Germany 8 131 0.8× 193 1.3× 80 0.6× 96 0.8× 88 0.9× 10 386
Julien Crettaz Spain 12 202 1.2× 151 1.0× 128 0.9× 194 1.7× 124 1.2× 17 474
Stephanie Drake United States 10 129 0.8× 54 0.4× 80 0.6× 192 1.7× 165 1.6× 14 440
Ruth Fulton United Kingdom 14 293 1.7× 205 1.4× 73 0.5× 243 2.1× 109 1.1× 21 581
Rita F. Buffett United States 10 159 0.9× 105 0.7× 41 0.3× 87 0.8× 57 0.6× 32 387
K E Dolter United States 10 90 0.5× 88 0.6× 60 0.4× 204 1.8× 93 0.9× 11 368
Svitlana P. Grekova Germany 10 313 1.8× 68 0.5× 236 1.6× 136 1.2× 32 0.3× 14 438
C. Van Sant United States 4 129 0.8× 150 1.0× 112 0.8× 214 1.9× 367 3.6× 5 546
Simona Doniņa Latvia 9 92 0.5× 61 0.4× 127 0.9× 100 0.9× 52 0.5× 25 306
M. Kathryn Liszewski United States 11 176 1.0× 67 0.4× 99 0.7× 252 2.2× 62 0.6× 12 396

Countries citing papers authored by Roswitha Gerhards

Since Specialization
Citations

This map shows the geographic impact of Roswitha Gerhards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roswitha Gerhards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roswitha Gerhards more than expected).

Fields of papers citing papers by Roswitha Gerhards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roswitha Gerhards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roswitha Gerhards. The network helps show where Roswitha Gerhards may publish in the future.

Co-authorship network of co-authors of Roswitha Gerhards

This figure shows the co-authorship network connecting the top 25 collaborators of Roswitha Gerhards. A scholar is included among the top collaborators of Roswitha Gerhards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roswitha Gerhards. Roswitha Gerhards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gerhards, Roswitha, et al.. (2010). Combined detection of Her2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer. Journal of Cancer Research and Clinical Oncology. 136(9). 1389–1400. 16 indexed citations
2.
Gerhards, Roswitha, et al.. (2002). Sequential immunochemotherapy and edrecolomab in the adjuvant therapy of breast cancer: reduction of 17-1A-positive disseminated tumour cells. Annals of Oncology. 13(7). 1044–1048. 25 indexed citations
3.
Dimmler, Arno, Roswitha Gerhards, Christoph Betz, et al.. (2001). Transcription of Cytokeratins 8, 18, and 19 in Bone Marrow and Limited Expression of Cytokeratins 7 and 20 by Carcinoma Cells: Inherent Limitations for RT-PCR in the Detection of Isolated Tumor Cells. Laboratory Investigation. 81(10). 1351–1361. 23 indexed citations
4.
Schneider, Thomas, Roswitha Gerhards, Elmar Kirches, & Raimund Firsching. (2001). Preliminary Results of Active Specific Immunization with Modified Tumor Cell Vaccine in Glioblastoma Multiforme. Journal of Neuro-Oncology. 53(1). 39–46. 53 indexed citations
6.
Haas, C, Christel Herold‐Mende, Roswitha Gerhards, & Volker Schirrmacher. (1999). An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules. Cancer Gene Therapy. 6(3). 254–262. 6 indexed citations
7.
Schirrmacher, Volker, et al.. (1998). Immunization with virus-modified tumor cells.. PubMed. 25(6). 677–96. 87 indexed citations
8.
Haas, C, et al.. (1998). Introduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus.. International Journal of Oncology. 13(6). 1105–15. 28 indexed citations
9.
Brüssow, Harald, D. R. Snodgrass, T. A. Fitzgerald, et al.. (1990). Antigenic and biochemical characterization of bovine rotavirus V1005, a new member of rotavirus serotype 10. Journal of General Virology. 71(11). 2625–2630. 14 indexed citations
10.
Gerhards, Roswitha, et al.. (1986). A set of stage‐dependent embryonic antigens expressed in cell cultures of BALB/c mouse embryos and in transformed cell lines. Journal of Cellular Biochemistry. 31(1). 27–39. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026